A novel personal protective equipment coverall was rated higher than standard Ebola virus personal protective equipment in terms of comfort, mobility and perception of safety when tested by health care workers in Liberia and in a United States biocontainment unit.


Journal

American journal of infection control
ISSN: 1527-3296
Titre abrégé: Am J Infect Control
Pays: United States
ID NLM: 8004854

Informations de publication

Date de publication:
03 2019
Historique:
received: 22 05 2018
revised: 11 08 2018
accepted: 12 08 2018
pubmed: 12 10 2018
medline: 9 4 2020
entrez: 11 10 2018
Statut: ppublish

Résumé

During the 2014-2016 Ebola virus epidemic, more than 500 health care workers (HCWs) died in spite of the use of personal protective equipment (PPE). The Johns Hopkins University Center for Bioengineering Innovation and Design (CBID) and Jhpiego, an international nongovernmental organization affiliate of Johns Hopkins, collaborated to create new PPE to improve the ease of the doffing process. HCWs in Liberia and a US biocontainment unit compared standard Médecins Sans Frontière PPE (PPE A) with the new PPE (PPE B). Participants wore each PPE ensemble while performing simulated patient care activities. Range of motion, time to doff, comfort, and perceived risk were measured. Overall, 100% of participants preferred PPE B over PPE A (P < .0001); 98.1% of respondents would recommend PPE B for their home clinical unit (P < .0001). There was a trend towards greater comfort in PPE B. HCWs at both sites felt more at risk in PPE A than PPE B (71.9% vs 25% in Liberia, P < .0001; 100% vs 40% in the US biocontainment unit, P < .0001). HCWs preferred a new PPE ensemble to Médecins Sans Frontière PPE for high-consequence pathogens. Further studies on the safety of this new PPE need to be conducted.

Sections du résumé

BACKGROUND
During the 2014-2016 Ebola virus epidemic, more than 500 health care workers (HCWs) died in spite of the use of personal protective equipment (PPE). The Johns Hopkins University Center for Bioengineering Innovation and Design (CBID) and Jhpiego, an international nongovernmental organization affiliate of Johns Hopkins, collaborated to create new PPE to improve the ease of the doffing process.
METHODS
HCWs in Liberia and a US biocontainment unit compared standard Médecins Sans Frontière PPE (PPE A) with the new PPE (PPE B). Participants wore each PPE ensemble while performing simulated patient care activities. Range of motion, time to doff, comfort, and perceived risk were measured.
RESULTS
Overall, 100% of participants preferred PPE B over PPE A (P < .0001); 98.1% of respondents would recommend PPE B for their home clinical unit (P < .0001). There was a trend towards greater comfort in PPE B. HCWs at both sites felt more at risk in PPE A than PPE B (71.9% vs 25% in Liberia, P < .0001; 100% vs 40% in the US biocontainment unit, P < .0001).
CONCLUSIONS
HCWs preferred a new PPE ensemble to Médecins Sans Frontière PPE for high-consequence pathogens. Further studies on the safety of this new PPE need to be conducted.

Identifiants

pubmed: 30301656
pii: S0196-6553(18)30841-1
doi: 10.1016/j.ajic.2018.08.014
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-304

Informations de copyright

Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. All rights reserved.

Auteurs

Brian T Garibaldi (BT)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Chandrakant Ruparelia (C)

Jhpiego-A Johns Hopkins University affiliate, Baltimore, MD. Electronic address: Chandrakant.ruparelia@jhpiego.org.

Kathryn Shaw-Saliba (K)

Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Lauren M Sauer (LM)

Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Lisa L Maragakis (LL)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Margaret Glancey (M)

Center for Bioengineering Innovation and Design, Johns Hopkins University, Baltimore, MD.

Marion Subah (M)

Jhpiego-A Johns Hopkins University affiliate, Baltimore, MD.

Allyson R Nelson (AR)

Jhpiego-A Johns Hopkins University affiliate, Baltimore, MD.

Colby Wilkason (C)

Center for Bioengineering Innovation and Design, Johns Hopkins University, Baltimore, MD.

Laura Scavo (L)

Center for Bioengineering Innovation and Design, Johns Hopkins University, Baltimore, MD.

Lindsay Litwin (L)

Jhpiego-A Johns Hopkins University affiliate, Baltimore, MD.

Patience Osei (P)

Center for Bioengineering Innovation and Design, Johns Hopkins University, Baltimore, MD.

Youseph Yazdi (Y)

Center for Bioengineering Innovation and Design, Johns Hopkins University, Baltimore, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH